S&T-22 PROGNOSTIC SIGNIFICANCE OF NEPHRECTOMY IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA TREATED WITH FIRST-LINE SYSTEMIC THERAPY: A 10-YEAR RETROSPECTIVE ANALYSIS ACCORDING TO MSKCC AND HENG RISK CRITERIA

who received post-operative radiotherapy or androgen deprivation therapy, and followed up for less than 1 year were excluded. The IPSS and QOL scores, ICIQ scores, Qmax and residual urine (RU), frequency of nocturia and pad consumption were compared at preoperative, postoperative 3, 6 and 12 months and statistically analyzed.